Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices

George J Arnaoutakis1, Timothy J George, Arman Kilic

  • 1Division of Cardiac Surgery, The Bloomberg School of Public Health, The Johns Hopkins Hospital, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

Insights

Patients bridged to heart transplant (BTT) with HeartMate II mechanical assistance face risks including age and HLA mismatch. Early survival improved at high-volume centers, aiding patient selection for this advanced therapy.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Mechanical Circulatory Support

Background:

  • Bridging to heart transplant (BTT) shows comparable outcomes to conventional orthotopic heart transplantation (OHT).
  • Limited data exists on risk factors for early mortality in BTT patients using mechanical assist devices.

Purpose of the Study:

  • To identify risk factors for early death in patients bridged to OHT with a HeartMate II.
  • To improve patient selection for HeartMate II as a bridge to transplantation.

Main Methods:

  • Retrospective review of the United Network for Organ Sharing database (2005-2010).
  • Analysis of 1,312 patients bridged to OHT with HeartMate II.
  • Multivariable Cox proportional hazards regression to identify predictors of 90-day mortality.

Main Results:

  • 13.0% of patients (171/1312) died within 90 days; unadjusted 90-day survival was 92.3%.
  • Risk factors for 90-day death included older age, lower glomerular filtration rate, African American race, HLA mismatch, elevated bilirubin, mechanical ventilation, donor age, and prolonged ischemia time.
  • Patients receiving OHT at high-volume centers demonstrated improved early survival (p=0.01).

Conclusions:

  • Identified key preoperative and intraoperative risk factors for early mortality in HeartMate II BTT recipients.
  • Findings will assist clinicians in selecting appropriate candidates for mechanical circulatory support as a bridge to heart transplantation.
  • High-volume center experience is associated with better early outcomes for BTT patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...